Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Beiersdorf price target raised to EUR 105 from EUR 101 at JPMorgan » 12:48
11/30/21
11/30
12:48
11/30/21
12:48
BDRFY

Beiersdorf

$20.14 /

-0.43 (-2.09%)

JPMorgan analyst Celine…

JPMorgan analyst Celine Pannuti raised the firm's price target on Beiersdorf to EUR 105 from EUR 101 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
BDRFY Beiersdorf
$20.14 /

-0.43 (-2.09%)

BDRFY Beiersdorf
$20.14 /

-0.43 (-2.09%)

11/02/21 Barclays
Beiersdorf price target lowered to EUR 120 from EUR 124 at Barclays
11/01/21 Bernstein
Beiersdorf upgraded to Market Perform from Underperform at Bernstein
10/29/21 JPMorgan
Beiersdorf price target lowered to EUR 101 from EUR 110 at JPMorgan
09/30/21 RBC Capital
Beiersdorf downgraded to Underperform from Sector Perform at RBC Capital
BDRFY Beiersdorf
$20.14 /

-0.43 (-2.09%)

Over a month ago
Recommendations
Beiersdorf price target lowered to EUR 120 from EUR 124 at Barclays » 14:35
11/02/21
11/02
14:35
11/02/21
14:35
BDRFY

Beiersdorf

$21.58 /

+0.3 (+1.41%)

Barclays analyst Iain…

Barclays analyst Iain Simpson lowered the firm's price target on Beiersdorf to EUR 120 from EUR 124 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
BDRFY Beiersdorf
$21.58 /

+0.3 (+1.41%)

BDRFY Beiersdorf
$21.58 /

+0.3 (+1.41%)

11/01/21 Bernstein
Beiersdorf upgraded to Market Perform from Underperform at Bernstein
10/29/21 JPMorgan
Beiersdorf price target lowered to EUR 101 from EUR 110 at JPMorgan
09/30/21 RBC Capital
Beiersdorf downgraded to Underperform from Sector Perform at RBC Capital
09/28/21 Bernstein
Beiersdorf downgraded to Underperform from Market Perform at Bernstein
BDRFY Beiersdorf
$21.58 /

+0.3 (+1.41%)

Upgrade
Beiersdorf upgraded to Market Perform from Underperform at Bernstein » 05:56
11/01/21
11/01
05:56
11/01/21
05:56
BDRFY

Beiersdorf

$21.28 /

-0.25 (-1.16%)

Bernstein analyst Bruno…

Bernstein analyst Bruno Monteyne upgraded Beiersdorf to Market Perform from Underperform. The stock is trading at a multi-year low and "will find support levels," Monteyne tells investors in a research note. The analyst says his sector concerns have played out with many companies having flagged margin pressure, bringing expectations down.

ShowHide Related Items >><<
BDRFY Beiersdorf
$21.28 /

-0.25 (-1.16%)

BDRFY Beiersdorf
$21.28 /

-0.25 (-1.16%)

10/29/21 JPMorgan
Beiersdorf price target lowered to EUR 101 from EUR 110 at JPMorgan
09/30/21 RBC Capital
Beiersdorf downgraded to Underperform from Sector Perform at RBC Capital
09/28/21 Bernstein
Beiersdorf downgraded to Underperform from Market Perform at Bernstein
09/21/21 Barclays
Beiersdorf price target lowered to EUR 124 from EUR 127 at Barclays
BDRFY Beiersdorf
$21.28 /

-0.25 (-1.16%)

Recommendations
Beiersdorf price target lowered to EUR 101 from EUR 110 at JPMorgan » 15:18
10/29/21
10/29
15:18
10/29/21
15:18
BDRFY

Beiersdorf

$21.53 /

-0.78 (-3.50%)

JPMorgan analyst Celine…

JPMorgan analyst Celine Pannuti lowered the firm's price target on Beiersdorf to EUR 101 from EUR 110 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
BDRFY Beiersdorf
$21.53 /

-0.78 (-3.50%)

BDRFY Beiersdorf
$21.53 /

-0.78 (-3.50%)

09/30/21 RBC Capital
Beiersdorf downgraded to Underperform from Sector Perform at RBC Capital
09/28/21 Bernstein
Beiersdorf downgraded to Underperform from Market Perform at Bernstein
09/21/21 Barclays
Beiersdorf price target lowered to EUR 124 from EUR 127 at Barclays
09/09/21 Goldman Sachs
Beiersdorf upgraded to Buy from Neutral at Goldman Sachs
BDRFY Beiersdorf
$21.53 /

-0.78 (-3.50%)

Downgrade
Beiersdorf downgraded to Underperform from Sector Perform at RBC Capital » 04:54
09/30/21
09/30
04:54
09/30/21
04:54
BDRFY

Beiersdorf

$22.20 /

-0.48 (-2.12%)

RBC Capital analyst Emma…

RBC Capital analyst Emma Letheren downgraded Beiersdorf to Underperform from Sector Perform with a price target of EUR 82, down from EUR 86. The company's sales outperformance prior to Covid-19 was a function of La Prairie whose growth "correlates uncannily closely" with consumer interest in China as captured by Google Trends, Letheren tells investors in a research note. Using this in a growth prediction model gives a "bleak outlook for the brand," says the analyst. Letheren adds that Beiersdorf's "seeming reluctance to step up brand equity investment only exacerbates an already difficult prognosis."

ShowHide Related Items >><<
BDRFY Beiersdorf
$22.20 /

-0.48 (-2.12%)

BDRFY Beiersdorf
$22.20 /

-0.48 (-2.12%)

09/28/21 Bernstein
Beiersdorf downgraded to Underperform from Market Perform at Bernstein
09/21/21 Barclays
Beiersdorf price target lowered to EUR 124 from EUR 127 at Barclays
09/09/21 Goldman Sachs
Beiersdorf upgraded to Buy from Neutral at Goldman Sachs
09/02/21 JPMorgan
Beiersdorf price target lowered to EUR 110 from EUR 112 at JPMorgan
BDRFY Beiersdorf
$22.20 /

-0.48 (-2.12%)

Downgrade
Beiersdorf downgraded to Underperform from Market Perform at Bernstein » 05:53
09/28/21
09/28
05:53
09/28/21
05:53
BDRFY

Beiersdorf

$23.15 /

-0.4975 (-2.10%)

Bernstein analyst Bruno…

Bernstein analyst Bruno Monteyne downgraded Beiersdorf to Underperform from Market Perform with a EUR 90 price target. The stock's recent rally "indicates high hopes" and is "disconnected from margin downgrades," Monteyne tells investors in a research note. The analyst sees Beiersdorf's margin pressures this year lasting well into 2022.

ShowHide Related Items >><<
BDRFY Beiersdorf
$23.15 /

-0.4975 (-2.10%)

BDRFY Beiersdorf
$23.15 /

-0.4975 (-2.10%)

09/21/21 Barclays
Beiersdorf price target lowered to EUR 124 from EUR 127 at Barclays
09/09/21 Goldman Sachs
Beiersdorf upgraded to Buy from Neutral at Goldman Sachs
09/02/21 JPMorgan
Beiersdorf price target lowered to EUR 110 from EUR 112 at JPMorgan
08/09/21 Barclays
Beiersdorf price target raised to EUR 127 from EUR 126 at Barclays
BDRFY Beiersdorf
$23.15 /

-0.4975 (-2.10%)

Recommendations
Beiersdorf price target lowered to EUR 124 from EUR 127 at Barclays » 12:29
09/21/21
09/21
12:29
09/21/21
12:29
BDRFY

Beiersdorf

$24.04 /

-0.29 (-1.19%)

Barclays analyst Iain…

Barclays analyst Iain Simpson lowered the firm's price target on Beiersdorf to EUR 124 from EUR 127 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
BDRFY Beiersdorf
$24.04 /

-0.29 (-1.19%)

BDRFY Beiersdorf
$24.04 /

-0.29 (-1.19%)

09/09/21 Goldman Sachs
Beiersdorf upgraded to Buy from Neutral at Goldman Sachs
09/02/21 JPMorgan
Beiersdorf price target lowered to EUR 110 from EUR 112 at JPMorgan
08/09/21 Barclays
Beiersdorf price target raised to EUR 127 from EUR 126 at Barclays
08/06/21 JPMorgan
Beiersdorf price target raised to EUR 112 from EUR 105 at JPMorgan
BDRFY Beiersdorf
$24.04 /

-0.29 (-1.19%)

Upgrade
Beiersdorf upgraded to Buy from Neutral at Goldman Sachs » 04:47
09/09/21
09/09
04:47
09/09/21
04:47
BDRFY

Beiersdorf

$24.42 /

+0.085 (+0.35%)

Goldman Sachs analyst…

Goldman Sachs analyst Olivier Nicolai upgraded Beiersdorf to Buy from Neutral with a EUR 122 price target. The company's turnaround story under the new CEO is not priced into the shares, Nicolai tells investors in a research note. The analyst believes the company's organic sales growth can reach 5%-plus mid term, on our estimates, while offering upside on margins after February's reset.

ShowHide Related Items >><<
BDRFY Beiersdorf
$24.42 /

+0.085 (+0.35%)

BDRFY Beiersdorf
$24.42 /

+0.085 (+0.35%)

09/02/21 JPMorgan
Beiersdorf price target lowered to EUR 110 from EUR 112 at JPMorgan
08/09/21 Barclays
Beiersdorf price target raised to EUR 127 from EUR 126 at Barclays
08/06/21 JPMorgan
Beiersdorf price target raised to EUR 112 from EUR 105 at JPMorgan
07/08/21 Morgan Stanley
Beiersdorf price target raised to EUR 85 from EUR 78 at Morgan Stanley
BDRFY Beiersdorf
$24.42 /

+0.085 (+0.35%)

Hot Stocks
Fly Intel: Top five weekend stock stories » 20:00
09/06/21
09/06
20:00
09/06/21
20:00
RYAAY

Ryanair

$107.97 /

+0.61 (+0.57%)

, BA

Boeing

$218.17 /

-2.62 (-1.19%)

, EADSY

Airbus

$33.99 /

-0.485 (-1.41%)

, BMWYY

BMW

$31.48 /

+0.075 (+0.24%)

, DDAIF

Daimler AG

$83.36 /

-0.263 (-0.31%)

, MRNA

Moderna

$416.61 /

+19.03 (+4.79%)

, BNTX

BioNTech

$334.00 /

+5.36 (+1.63%)

, XLRN

Acceleron

$131.13 /

-0.47 (-0.36%)

, NVTA

Invitae

$31.25 /

+0.2 (+0.64%)

, SRPT

Sarepta

$80.54 /

+1.09 (+1.37%)

, CMPS

Compass Pathways

$33.16 /

+0.04 (+0.12%)

, ALVR

AlloVir

$20.24 /

+0.17 (+0.85%)

, DIS

Disney

$180.96 /

-0.87 (-0.48%)

, TMHC

Taylor Morrison

$27.83 /

-0.305 (-1.08%)

, BDRFY

Beiersdorf

$24.36 /

-0.06 (-0.25%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Ryanair (RYAAY), Boeing's (BA) biggest customer outside of the U.S., said it is walking away from talks with the U.S. jet maker over a potential new order for the 737 MAX in a dispute over pricing, The Wall Street Journal's Benjamin Katz reported. Boeing has pushed to catch up with rival Airbus (EADSY) on jet orders from airlines and lessors, after falling far behind in the crucial single-aisle category, the author noted. The 737 MAX competes with Airbus's A320 in that market, and Airbus capitalized on the MAX's nearly two-year grounding to boost its market share. 2. BMW (BMWYY) expects supply chains to remain tight well into 2022, Chief Executive Oliver Zipse said on Monday, squashing hopes that a painful shortage of crucial semiconductors will end soon, according to Reuters. "I expect that the general tightness of the supply chains will continue in the next 6 to 12 months," he said at the IAA Munich car show. Meanwhile, Daimler's (DDAIF) CEO also said that soaring demand for semiconductor chips means the auto industry could struggle to source enough of them throughout next year and into 2023, though the shortage should be less severe by then, Reuters' Ilona Wissenbach and Nick Carey reported. "Several chip suppliers have been referring to structural problems with demand," Ola Kallenius told reporters during a roundtable event ahead of the Munich IAA car show. "This could influence 2022 and (the situation) may be more relaxed in 2023." 3. The market is littered with biotech stocks whose prices have fallen by more than half since the start of the year, with Moderna (MRNA) and BioNTech (BNTX) the exception in the sector, Josh Nathan-Kazis wrote in this week's edition of Barron's. There have been renewed signs in recent weeks, however, of substantial value hiding among the biotech dross, the author notes. Acceleron Pharma (XLRN), Invitae (NVTA), Sarepta Therapeutics (SRPT), Compass Pathways (CMPS) and AlloVir (ALVR) are among favorites in the depressed sector, the publication added. 4. Disney's (DIS) "Shang-Chi and the Legend of the Ten Rings" smashed the record for Labor Day openings with a four-day total of $90M. This is also the second-biggest three-day debut of the pandemic to date, behind another Marvel Studios' title: "Black Widow." "Shang-Chi" earned $75.5M for the three days and will have an exclusive 45-day theatrical release. 5. Taylor Morrison (TMHC) and Beiersdorf (BDRFY) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
XLRN Acceleron
$131.13 /

-0.47 (-0.36%)

TMHC Taylor Morrison
$27.83 /

-0.305 (-1.08%)

SRPT Sarepta
$80.54 /

+1.09 (+1.37%)

RYAAY Ryanair
$107.97 /

+0.61 (+0.57%)

NVTA Invitae
$31.25 /

+0.2 (+0.64%)

MRNA Moderna
$416.61 /

+19.03 (+4.79%)

EADSY Airbus
$33.99 /

-0.485 (-1.41%)

DIS Disney
$180.96 /

-0.87 (-0.48%)

DDAIF Daimler AG
$83.36 /

-0.263 (-0.31%)

CMPS Compass Pathways
$33.16 /

+0.04 (+0.12%)

BNTX BioNTech
$334.00 /

+5.36 (+1.63%)

BMWYY BMW
$31.48 /

+0.075 (+0.24%)

BA Boeing
$218.17 /

-2.62 (-1.19%)

ALVR AlloVir
$20.24 /

+0.17 (+0.85%)

RYAAY Ryanair
$107.97 /

+0.61 (+0.57%)

07/27/21 Redburn
Ryanair upgraded to Buy from Neutral at Redburn
07/12/21 Morgan Stanley
Ryanair price target raised to EUR 20 from EUR 17 at Morgan Stanley
07/12/21 JPMorgan
Ryanair price target raised to EUR 16.40 from EUR 15.80 at JPMorgan
07/12/21 Evercore ISI
Evercore upgrades 'high quality laggard' Ryanair to Outperform
BA Boeing
$218.17 /

-2.62 (-1.19%)

09/01/21 Susquehanna
Boeing delivery estimates lowered due to continued suspension, says Susquehanna
08/19/21 Cowen
China may not certify 737 MAX by Boeing's year-end target, says Cowen
08/06/21 BofA
BofA double upgrades Spirit AeroSystems to Buy, sees pullback as overdone
07/30/21 BofA
Albany International upgraded to Buy from Neutral at BofA
EADSY Airbus
$33.99 /

-0.485 (-1.41%)

08/04/21 Deutsche Bank
Airbus price target raised to EUR 131 from EUR 122 at Deutsche Bank
07/30/21 JPMorgan
Airbus price target raised to EUR 160 from EUR 138 at JPMorgan
07/30/21 Credit Suisse
Airbus price target raised to EUR 137 from EUR 134 at Credit Suisse
BMWYY BMW
$31.48 /

+0.075 (+0.24%)

08/20/21 Erste Group
BMW downgraded to Hold from Buy at Erste Group
08/11/21 Barclays
BMW price target lowered to EUR 95 from EUR 108 at Barclays
08/09/21 Societe Generale
BMW price target raised to EUR 115 from EUR 112 at Societe Generale
07/09/21 Oddo BHF
BMW upgraded to Neutral from Underperform at Oddo BHF
DDAIF Daimler AG
$83.36 /

-0.263 (-0.31%)

08/11/21 Barclays
Daimler AG price target lowered to EUR 110 from EUR 115 at Barclays
08/09/21 Jefferies
Daimler AG downgraded to Hold from Buy at Jefferies
08/01/21 Goldman Sachs
Daimler AG upgraded to Conviction Buy from Buy at Goldman Sachs
07/23/21 Kepler Cheuvreux
Daimler AG upgraded to Buy at Kepler Cheuvreux following pullback
MRNA Moderna
$416.61 /

+19.03 (+4.79%)

08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
08/06/21 Oppenheimer
Moderna downgraded to Perform from Outperform at Oppenheimer
08/06/21 Piper Sandler
Moderna downgraded to Neutral from Overweight at Piper Sandler
BNTX BioNTech
$334.00 /

+5.36 (+1.63%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/11/21 H.C. Wainwright
BioNTech price target raised to $330 from $194 at H.C. Wainwright
XLRN Acceleron
$131.13 /

-0.47 (-0.36%)

08/05/21 Piper Sandler
Acceleron price target raised to $146 from $143 at Piper Sandler
07/19/21 Wolfe Research
Acceleron assumed with an Outperform at Wolfe Research
06/24/21 Oppenheimer
Acceleron price target raised to $160 from $141 at Oppenheimer
06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
NVTA Invitae
$31.25 /

+0.2 (+0.64%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
SRPT Sarepta
$80.54 /

+1.09 (+1.37%)

08/05/21 JPMorgan
Sarepta upgraded to Neutral after 60% selloff at JPMorgan
08/05/21 JPMorgan
Sarepta upgraded to Neutral from Underweight at JPMorgan
07/01/21 Berenberg
Sarepta assumed with a Hold at Berenberg
06/14/21 BTIG
Sarepta initiated with a Buy at BTIG
CMPS Compass Pathways
$33.16 /

+0.04 (+0.12%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
ALVR AlloVir
$20.24 /

+0.17 (+0.85%)

06/14/21 Piper Sandler
AlloVir remains a top small-cap pick at Piper Sandler
03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/22/21 Piper Sandler
AlloVir remains a top 2021 pick at Piper Sandler
02/11/21 Piper Sandler
AlloVir price target raised to $55 from $52 at Piper Sandler
DIS Disney
$180.96 /

-0.87 (-0.48%)

08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/27/21 Deutsche Bank
Disney price target lowered to $200 from $213 at Deutsche Bank
08/16/21 Argus
Disney's TV, theme park, DTC businesses to gain further momentum, Argus says
08/13/21 RBC Capital
Disney price target raised to $210 from $202 at RBC Capital
TMHC Taylor Morrison
$27.83 /

-0.305 (-1.08%)

07/19/21 BTIG
Taylor Morrison price target lowered to $35 from $42 at BTIG
04/15/21 Wells Fargo
Taylor Morrison initiated with an Equal Weight at Wells Fargo
03/16/21 Wolfe Research
Taylor Morrison initiated with a Peer Perform at Wolfe Research
02/22/21 KeyBanc
Taylor Morrison initiated with a Sector Weight at KeyBanc
BDRFY Beiersdorf
$24.36 /

-0.06 (-0.25%)

09/02/21 JPMorgan
Beiersdorf price target lowered to EUR 110 from EUR 112 at JPMorgan
08/09/21 Barclays
Beiersdorf price target raised to EUR 127 from EUR 126 at Barclays
08/06/21 JPMorgan
Beiersdorf price target raised to EUR 112 from EUR 105 at JPMorgan
07/08/21 Morgan Stanley
Beiersdorf price target raised to EUR 85 from EUR 78 at Morgan Stanley
XLRN Acceleron
$131.13 /

-0.47 (-0.36%)

TMHC Taylor Morrison
$27.83 /

-0.305 (-1.08%)

SRPT Sarepta
$80.54 /

+1.09 (+1.37%)

NVTA Invitae
$31.25 /

+0.2 (+0.64%)

MRNA Moderna
$416.61 /

+19.03 (+4.79%)

EADSY Airbus
$33.99 /

-0.485 (-1.41%)

DIS Disney
$180.96 /

-0.87 (-0.48%)

DDAIF Daimler AG
$83.36 /

-0.263 (-0.31%)

CMPS Compass Pathways
$33.16 /

+0.04 (+0.12%)

BNTX BioNTech
$334.00 /

+5.36 (+1.63%)

BMWYY BMW
$31.48 /

+0.075 (+0.24%)

BA Boeing
$218.17 /

-2.62 (-1.19%)

ALVR AlloVir
$20.24 /

+0.17 (+0.85%)

  • 30
    Apr
  • 22
    Jan
  • 18
    Sep
TMHC Taylor Morrison
$27.83 /

-0.305 (-1.08%)

RYAAY Ryanair
$107.97 /

+0.61 (+0.57%)

NVTA Invitae
$31.25 /

+0.2 (+0.64%)

MRNA Moderna
$416.61 /

+19.03 (+4.79%)

EADSY Airbus
$33.99 /

-0.485 (-1.41%)

DIS Disney
$180.96 /

-0.87 (-0.48%)

DDAIF Daimler AG
$83.36 /

-0.263 (-0.31%)

BNTX BioNTech
$334.00 /

+5.36 (+1.63%)

BMWYY BMW
$31.48 /

+0.075 (+0.24%)

BDRFY Beiersdorf
$24.36 /

-0.06 (-0.25%)

BA Boeing
$218.17 /

-2.62 (-1.19%)

SRPT Sarepta
$80.54 /

+1.09 (+1.37%)

RYAAY Ryanair
$107.97 /

+0.61 (+0.57%)

NVTA Invitae
$31.25 /

+0.2 (+0.64%)

MRNA Moderna
$416.61 /

+19.03 (+4.79%)

EADSY Airbus
$33.99 /

-0.485 (-1.41%)

DIS Disney
$180.96 /

-0.87 (-0.48%)

DDAIF Daimler AG
$83.36 /

-0.263 (-0.31%)

CMPS Compass Pathways
$33.16 /

+0.04 (+0.12%)

BNTX BioNTech
$334.00 /

+5.36 (+1.63%)

BMWYY BMW
$31.48 /

+0.075 (+0.24%)

BA Boeing
$218.17 /

-2.62 (-1.19%)

NVTA Invitae
$31.25 /

+0.2 (+0.64%)

MRNA Moderna
$416.61 /

+19.03 (+4.79%)

DIS Disney
$180.96 /

-0.87 (-0.48%)

BA Boeing
$218.17 /

-2.62 (-1.19%)

Over a quarter ago
Periodicals
Beiersdorf working on turnaround, stock looks attractive, Barron's says » 08:47
09/04/21
09/04
08:47
09/04/21
08:47
BDRFY

Beiersdorf

$24.36 /

-0.06 (-0.25%)

Beiersdorf, the German…

Beiersdorf, the German personal-care products maker that owns the Nivea and La Prairie brands, had a few tough years before the pandemic, and it went downhill from there, Rupert Steiner writes in this week's edition of Barron's. But CEO Vincent Warnery took the helm in May and has made his mark in Beiersdorf's dermatological division, which includes the Eucerin and Aquaphor brands, and under his leadership, the company has expanded its global footprint and developed new products, the author notes. As a result, the company produced double-digit growth across its brands in the first half of this year, he adds. Reference Link

ShowHide Related Items >><<
BDRFY Beiersdorf
$24.36 /

-0.06 (-0.25%)

09/02/21 JPMorgan
Beiersdorf price target lowered to EUR 110 from EUR 112 at JPMorgan
08/09/21 Barclays
Beiersdorf price target raised to EUR 127 from EUR 126 at Barclays
08/06/21 JPMorgan
Beiersdorf price target raised to EUR 112 from EUR 105 at JPMorgan
07/08/21 Morgan Stanley
Beiersdorf price target raised to EUR 85 from EUR 78 at Morgan Stanley

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.